Compounds > quinapril
Page last updated: 2024-08-23

quinapril and Obesity

quinapril has been researched along with Obesity in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's6 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanco, S; Casas, I; López, D; Penin, R; Romero, R1
Crook, E; Dudley, A; Flack, JM; Mokwe, E; Nasser, SA; Ohmit, SE; Saunders, E; Shafi, T1
Blanco, S; Bonet, J; Casas, I; López, D; Romero, R1
Blanco, S; Egido, J; Gómez-Guerrero, C; López, D; Romero, R; Vaquero, M1
Cheema, F; Khan, BV; Khan, QA; Merchant, N; Nagamia, S; Natarajan, R; Pandian, A; Patel, AD; Sola, S1
Araújo, D; Cabezas-Cerrato, J; Garcia-Estevez, DA; Iglesias, M1
Mchaourab, A; Sarantopoulos, C; Stowe, DF1
Ferder, LF; Inserra, F; Porter, JR; Reisin, E; Richards, RJ; Stella, I; Svec, F1

Trials

2 trial(s) available for quinapril and Obesity

ArticleYear
Determinants of blood pressure response to quinapril in black and white hypertensive patients: the Quinapril Titration Interval Management Evaluation trial.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:6

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Diabetes Complications; Diastole; Dose-Response Relationship, Drug; Female; Genetic Variation; Humans; Hypertension; Male; Middle Aged; Obesity; Quinapril; Systole; Tetrahydroisoquinolines; Treatment Outcome; United States; White People

2004
The role of quinapril in the presence of a weight loss regimen: endothelial function and markers of obesity in patients with the metabolic syndrome.
    Preventive cardiology, 2007,Fall, Volume: 10, Issue:4

    Topics: Adiponectin; Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Leptin; Male; Metabolic Syndrome; Middle Aged; Obesity; Prognosis; Quinapril; Tetrahydroisoquinolines; Vasodilation; Weight Loss

2007

Other Studies

6 other study(ies) available for quinapril and Obesity

ArticleYear
Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
    Kidney international. Supplement, 2002, Issue:82

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; Disease Models, Animal; Drug Therapy, Combination; Linear Models; Male; Obesity; Podocytes; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines

2002
ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
    Kidney international. Supplement, 2005, Issue:93

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Calcium Channel Blockers; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diltiazem; DNA, Complementary; Immunoenzyme Techniques; Male; Membrane Proteins; Microfilament Proteins; Obesity; Proteins; Quinapril; Rats; Rats, Zucker; Reverse Transcriptase Polymerase Chain Reaction; RNA; Tetrahydroisoquinolines

2005
Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    American journal of hypertension, 2005, Volume: 18, Issue:4 Pt 1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atorvastatin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunoenzyme Techniques; Kidney; Kidney Glomerulus; Linear Models; Microscopy, Electron; Obesity; Pyrroles; Quinapril; Rats; Rats, Zucker; Staining and Labeling; Tetrahydroisoquinolines

2005
Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
    Metabolism: clinical and experimental, 1997, Volume: 46, Issue:2

    Topics: Adolescent; Adult; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diltiazem; Glucose Tolerance Test; Humans; Hypertension; Insulin Resistance; Islets of Langerhans; Isoquinolines; Male; Middle Aged; Obesity; Quinapril; Tetrahydroisoquinolines

1997
Airway obstruction due to late-onset angioneurotic edema from angiotensin-converting enzyme inhibition.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1999, Volume: 46, Issue:10

    Topics: Airway Obstruction; Anesthesia, General; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Transitional Cell; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Obesity; Quinapril; Tetrahydroisoquinolines; Urinary Bladder Neoplasms

1999
Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats.
    Kidney international, 2001, Volume: 59, Issue:1

    Topics: Actins; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Dehydroepiandrosterone; Diuresis; Isoquinolines; Kidney; Kidney Diseases; Muscle, Smooth; Natriuresis; Obesity; Organ Size; Proteinuria; Quinapril; Rats; Rats, Zucker; Tetrahydroisoquinolines; Thinness; Tissue Distribution

2001